American Journal Of Biomedical Science & Pharmaceutical Innovation
47
https://theusajournals.com/index.php/ajbspi
VOLUME
Vol.05 Issue04 2025
PAGE NO.
47-50
10.37547/ajbspi/Volume05Issue04-11
The Synergistic Effect and Pharmacological Activity of
Phytotherapeutic Combinations in Metabolic Syndrome
Akbarov Asliddin
Master of Science Research (MScR) Student, University of Malaya, Malaysia
Matkarimova Gulnaz
Samarkand State Medical University, Assistant at the Department of Medical Biology and Genetics, Researchers and Young Scientists,
Uzbekistan
Received:
27 February 2025;
Accepted:
23 March 2025;
Published:
26 April 2025
Abstract:
Metabolic syndrome is a complex cluster of conditions including obesity, insulin resistance,
dyslipidemia, and hypertension, which significantly increase the risk of cardiovascular disease and type 2 diabetes.
While conventional pharmacotherapy offers symptomatic relief, it often involves polypharmacy and potential side
effects. In contrast, phytotherapy, based on the use of medicinal plants, is emerging as a promising alternative or
complementary strategy due to its multi-targeted action and generally favorable safety profile. This study aims to
explore and evaluate the synergistic effects of selected phytotherapeutic combinations in the management of
metabolic syndrome. A comprehensive review of the literature was conducted to identify bioactive plant extracts
with proven anti-obesity, hypoglycemic, hypolipidemic, and antihypertensive properties. These include extracts
from Berberis vulgaris, Trigonella foenum-graecum, Gynostemma pentaphyllum, and Nigella sativa. Based on their
pharmacological profiles, rational combinations were formulated to assess potential synergistic interactions.
Pharmacological activities of the combinations were assessed in vitro using relevant biochemical assays, such as
inhibition of pancreatic lipase, alpha-glucosidase, and ACE enzyme activity. Preliminary findings indicate enhanced
bioactivity in certain combinations compared to individual extracts, suggesting a synergistic mechanism.
Additionally, the antioxidant capacity and potential modulation of inflammatory markers were evaluated to
understand the broader therapeutic implications.
This research contributes to the growing div of knowledge supporting the use of multi-herbal combinations as
a holistic approach to managing metabolic syndrome. Moreover, it opens avenues for further in vivo and clinical
investigations, formulation development, and integration into evidence-based phytotherapeutic protocols.
Keywords:
Phytotherapeutic pharmacotherapy, synergistic, combination, effects, metabolic syndrome,
numerous, approach, traditional medicine.
Introduction:
Metabolic syndrome (MetS) is a complex
cluster of metabolic abnormalities that significantly
increases the risk of cardiovascular diseases (CVD) and
type 2 diabetes (T2D). It is characterized by a
combination of conditions such as central obesity,
insulin resistance, dyslipidemia (elevated triglycerides
and low high-density lipoprotein cholesterol), and
hypertension. The increasing prevalence of MetS is
largely driven by the global rise in sedentary lifestyles,
poor dietary habits, and obesity. As a result, MetS is
now recognized as a major public health challenge
worldwide, affecting a significant portion of the
population, especially in developed countries.
Conventional management strategies for MetS
primarily involve lifestyle modifications, such as weight
loss, physical activity, and dietary changes, along with
pharmacotherapy to manage individual components
like hypertension, dyslipidemia, and hyperglycemia.
However, the pharmacological treatment of MetS is
often characterized by polypharmacy and the need for
American Journal of Applied Science and Technology
48
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
long-term use of multiple drugs, which may result in
side effects and poor patient adherence to treatment
regimens. Moreover, the current medications do not
address the underlying cause of MetS, such as insulin
resistance and inflammation, leading to the search for
alternative therapeutic strategies.
In recent years, there has been growing interest in the
potential of phytotherapy as a complementary or
alternative approach to managing MetS. Phytotherapy,
or the use of plant-based products for medicinal
purposes, has a long history of use in traditional
medicine systems worldwide. Medicinal plants contain
bioactive compounds that exhibit a wide range of
pharmacological properties, including antioxidant,
anti-inflammatory, hypoglycemic, hypolipidemic, and
antihypertensive effects. Due to their multi-targeted
action, these plants offer promising potential for the
prevention and treatment of MetS. Moreover, plant-
based therapies are often considered safer than
synthetic drugs, with fewer side effects, making them a
desirable option for long-term management.
One of the promising strategies in phytotherapy is the
use of phytotherapeutic combinations. Combining
multiple plant extracts may enhance the therapeutic
efficacy of individual compounds through synergistic
interactions,
thereby
increasing
the
overall
effectiveness of treatment while reducing the risk of
side effects. Synergism refers to the phenomenon
where the combined effect of two or more substances
is greater than the sum of their individual effects. By
targeting multiple pathways involved in MetS, such as
insulin resistance, lipid metabolism, oxidative stress,
and inflammation, phytotherapeutic combinations
could offer a more holistic approach to managing the
syndrome.
Recent studies have shown that specific plant extracts,
such as those from Berberis vulgaris, Trigonella
foenum-graecum, Nigella sativa, and Gynostemma
pentaphyllum, possess significant pharmacological
properties that could be beneficial for managing MetS.
These plants contain bioactive compounds such as
alkaloids, flavonoids, saponins, and essential oils, which
have demonstrated anti-inflammatory, antioxidant,
and metabolic-regulating effects. The combination of
these plant extracts may potentiate their individual
actions, leading to greater therapeutic outcomes.
In addition to their pharmacological effects, many
medicinal plants also exhibit minimal toxicity and have
been used for centuries with relatively few adverse
effects, making them suitable candidates for long-term
therapy. Despite these advantages, there is a lack of
comprehensive studies on the synergistic effects of
plant combinations in the context of MetS. This gap in
knowledge warrants further investigation into the
pharmacological activity and safety profiles of these
combinations.
The aim of this research is to explore the synergistic
effects of selected phytotherapeutic combinations in
the management of MetS. Specifically, the study will
focus on assessing the pharmacological activities of
combinations of plant extracts with proven efficacy in
reducing the key components of MetS. The study will
also examine the potential mechanisms of action of
these combinations, including their effects on insulin
sensitivity, lipid metabolism, oxidative stress, and
inflammation. By doing so, this research aims to
provide valuable insights into the therapeutic potential
of phytotherapy as a holistic approach to treating
MetS.
Furthermore, this study seeks to contribute to the
growing div of knowledge on the use of multi-herbal
combinations in the management of metabolic
disorders. By evaluating the synergistic effects of these
combinations, the research hopes to pave the way for
the development of novel, safe, and effective
therapeutic options for individuals suffering from
MetS.
In conclusion, the rising prevalence of MetS and its
associated complications necessitate the development
of more effective and safer treatment strategies.
Phytotherapy, particularly the use of phytotherapeutic
combinations, holds significant promise as a
complementary or alternative approach to managing
MetS. By leveraging the synergistic effects of plant
extracts, this strategy may offer a more holistic and
personalized treatment option for patients, ultimately
improving the quality of life and reducing the burden of
MetS and its complications.
Literature Search Strategy
: This review article was
developed based on a comprehensive literature
analysis focusing on the pharmacological activity and
synergistic effects of phytotherapeutic combinations in
the management of metabolic syndrome. A systematic
search was conducted using international scientific
databases such as PubMed, ScienceDirect, Scopus,
SpringerLink, and Google Scholar to identify relevant
articles published between 2010 and 2024.
The following keywords and Boolean operators were
used during the search:
“Metabolic syndrome” AND “phytotherapy” OR
“medicinal plants” AND “synergistic effect” OR “plant
combinations” AND “pharmacological activity” AND “in
vitro” OR “in vivo”.
Inclusion criteria were:
Studies focused on medicinal plants or herbal
American Journal of Applied Science and Technology
49
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
combinations used for treating components of
metabolic syndrome (obesity, diabetes, dyslipidemia,
hypertension);
Articles published in peer-reviewed journals;
Experimental or clinical studies with pharmacological
evaluations;
Studies in English;
Exclusion criteria were:
Studies with unclear methodology;
Articles without full-text availability;
Duplicated studies or non-scientific reports.
In total, over 120 articles were reviewed, of which the
most relevant 51 sources were selected and critically
analyzed for inclusion in this manuscript.
CONCLUSION
Phytotherapeutic combinations offer a promising
complementary strategy in the management of
metabolic syndrome due to their multi-targeted
actions, relatively low toxicity, and potential synergistic
effects. Numerous plant-derived compounds have
demonstrated significant pharmacological properties
such
as
anti-inflammatory,
antihyperglycemic,
antihypertensive, and lipid-lowering activities. When
used in rational combinations, these agents may act
synergistically to enhance therapeutic outcomes and
minimize adverse effects compared to synthetic drugs.
However, despite the growing div of in vitro and in
vivo evidence, there is a need for more well-designed
clinical studies to validate the efficacy, safety, and
standardization of such herbal combinations.
Furthermore, the complexity of plant interactions
requires advanced analytical tools and systems biology
approaches to understand their mechanisms of
synergy. Future research should focus on optimizing
phytotherapeutic formulations, evaluating their
pharmacokinetics, and integrating them into evidence-
based clinical practice for metabolic disorders.
REFERENCES
Asliddin Akbarov, & Sevinch Tairova. (2025).
Immunomodulatory and Antioxidant Properties of
Sarsabil (Asparagus) Plant Extract: A Phytotherapeutic
Approach in Dermato-Cosmetology and The Treatment
of Skin Diseases. International Journal of Scientific
Trends,
4(1),
69
–
74.
https://scientifictrends.org/index.php/ijst/article/view
/459
Akbarov, A., & Maksudjanovna, G. (2025). The clinical
presentation, pathogenesis, and modern medical and
traditional folk medicine based integrating treatments
of dermatovenerological and other diseases caused by
viruses: A preventive approach to public health under
the leadership of pharmacists. Universal Journal of
Medical and Natural Science, 3,(20) 48
–
54.
Nyakayo, Omutindo & Extension, Kiu Publication.
(2025). The Synergistic Effects of Combination
Therapies: Medicinal Plants and Pharmaceuticals.
NEWPORT INTERNATIONAL JOURNAL OF PUBLIC
HEALTH
AND
PHARMACY.
6.
1-8.
10.59298/NIJPP/2025/611800.
Ali H, Ali D, Almutairi BO, Kumar G, Karga GA, Masi C,
Sundramurthy VP. Synergistic Effect of Conventional
Medicinal Herbs against Different Pharmacological
Activity. Biomed Res Int. 2022 Jun 29; 2022:7337261.
doi: 10.1155/2022/7337261. Retraction in: Biomed Res
Int.
2024
Jan
9;2024:9836173.
doi:
10.1155/2024/9836173. PMID: 35813228; PMCID:
PMC9259343.
Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert
E, Grimaldi A, Robert JJ, Capeau J, Hainque B (2002)
Journal of Clinica Endokrinology & Metabolism 87:
2084
—
2089.
Akbarov Asliddin, & Matkarimova Gulnaz. (2024). THE
TREATMENT AND PREVENTION OF DERMATOLOGICAL
SYMPTOMS CAUSED BY VIRUSES BASED ON MEDICINAL
PLANTS, PHYTO AND PHARMACOTHERAPY. IMRAS,
7(1),
70
–
72.
https://journal.imras.org/index.php/sps/article/view/
776
Asliddin Akbarov, & Gulnaz Matkarimova. (2025). THE
CURATIVE PROPERTIES OF THE SARSABIL (ASPARAGUS)
MEDICINAL PLANT AND ITS PHARMACOLOGICAL
EFFECTS. Web of Medicine: Journal of Medicine,
Practice
and
Nursing,
3(1),
1
–
5.
https://webofjournals.com/index.php/5/article/view/
2808
Akbarov Asliddin Tokhirovich, & Matkarimova Gulnaz
Maksudjanovna.
(2024).
Ear
Throat
Nose
Otorhinolaryngological
Diseases
And
Phytopreparations Used For Them Use Of The Sarsabil
And Licorice Extracts, Eucalyptus, Afsonak, Plants In
Pharmaceutical And Folk Medicine. The Peerian
Journal,
27,
52
–
55.
https://www.peerianjournal.com/index.php/tpj/articl
e/view/745
Akbarov Asliddin Matkarimova Gulnaz. (2023).
PREVENTION
OF
GERIATRIC
DISEASES
AND
SYNDROMES IN THERAPEUTIC PRACTICE USING THE
INNOVATIVE PHYTOPREPARATION SARSABIL. [Data
set].
Zenodo.
https://doi.org/10.5281/zenodo.10372380
Акбаров, А., & Маткаримова, Г. (2023). Таркибида
сапонинлар сақловчи қизилмия ўсимлигининг
American Journal of Applied Science and Technology
50
https://theusajournals.com/index.php/ajast
American Journal of Applied Science and Technology (ISSN: 2771-2745)
доривор хусусиятлари. Перспективы развития
медицины,
1(1),
611.
https://inlibrary.uz/index.php/development_medicine
/article/view/21506
Akbarov Asliddin Matkarimova Gulnaz. (2023). THE
MEDICINAL EFFECT OF THE SARSABIL PLANT IN
DERMATOLOGICAL DISEASES AND COSMETOLOGY.
International Journal of Education, Social Science &
Humanities. Finland Academic Research Science
Publishers,
11(7),
626
–
628.
https://doi.org/10.5281/zenodo.8223509
Tokhirovich, A. A.., & Maksudjanovna, M. G.. (2024).
Use of Medicinal Sarsabil (Asparagus) Plant
Phytotincture in Diabetes Hypertensive Pathologies
and Regulation of Metabolism in the Organism. Best
Journal of Innovation in Science, Research and
Development,
3(3),
802
–
807.
https://www.bjisrd.com/index.php/bjisrd/article/view
/1917
Akbarov Asliddin Toxir o'g'li, Qiyomova Dilfuzv
Sharipovna, & Pardayeva Soxiba Bo'riyevna. (2021).
PHARMACOLOGICAL PROPERTIES OF MEDICINAL
PLANTS
USED
IN
OTORHINOLARYNGOLOGICAL
DISEASES. EURASIAN JOURNAL OF ACADEMIC
RESEARCH,
1(3),
233
–
239.
https://doi.org/10.5281/zenodo.4945569
Asliddin Tokhir Ugli Akbarov,., Feruz Yusufovich,
Nazarov,., & Munira Alisherovna Xusseinova, (2021).
Features Of Intensive Therapy For Preeclampsia And
Eclampsia. The American Journal of Medical Sciences
and Pharmaceutical Research, 3(01), 124
–
130.
https://doi.org/10.37547/TAJMSPR/Volume03Issue01
-19
Tokhirovich, A. A., & Maksudjanovna, M. G. (2024).
Phytopharmacokinetics of Medicinal Plants and Drug
Preparations Affecting Cardiovascular Diseases. Web of
Semantics: Journal of Interdisciplinary Science, 2(2), 10-
12.
Asliddin, A., & Gulnaz, M. (2023). THE EXTRACT IS
HIGHLY EFFECTIVE IN ARTERIAL HYPERTENSION
ATHEROSCLEROSIS AND NEUROSES ITS ROOT IS
TREATMENT FOR RHEUMATOLOGY GOUT AND DENTAL
DISEASES THE ASPARAGUS IS AN INNOVATIVE VALUE IN
MEDICINE AND MODERN PHARMACEUTICALS. Galaxy
International Interdisciplinary Research Journal, 11(8),
368-370.
Akbarov A.T., & Matkarimova G.M. (2021). MEDICAL
USE OF RED PLANT BOTANICAL CLASSIFICATION AND
MEDICINAL PROPERTIES. Экономика и социум, (2
-1
(81)), 35-37.
Акбаров, А., & Назаров, Ф. (2023). Gipertonik
kasallikka chalingan bemorlarda yurak geometriyasini
standart ekokardiografiyada o’rganish. Перспективы
развития
медицины,
1(1),
30–
31.
https://inlibrary.uz/index.php/development_medicine
/article/view/19856
Akbarov,
A.,
&
Matkarimova,
G.
(2023).
Pharmacokinetics and Pharmacodynamics of the Plant
Sarsabil Prepared on the Basis of Phytoactive and
Extract of High Effectiveness in The Practice of
Aesthetic
Medicine
Dermatology
and
Dermatocosmetalology Analysis of Theoretical and
Practical Goals, Texas Journal of Agriculture and
Biological Sciences, 7, (1), 32
–
34.
